Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
Patients were first observed for a 4-week baseline period, which required no medication adjustments and a seizure frequency of greater than or equal to 2 times per 4-week . After the baseline observation period, if the patients met the criteria for enrolment and there were no contraindications, zonisamide was added as an additional therapeutic drug.Clinical data were collected before the initiation of treatment, at 1 month, 3 months and 6 months after taking zonisamide respectively, with regular review of blood tests and urinary ultrasound, and imaging and electrophysiological examinations according to the clinical needs of the patient's actual condition.
Key Details
Gender
All
Age Range
2 Years - Any
Study Type
OBSERVATIONAL
Enrollment
400
Start Date
2024-04
Completion Date
2025-12
Last Updated
2024-04-19
Healthy Volunteers
No
Conditions
Interventions
Zonisamide
This is a real-world study,so we prospectively enrolled patients with focal epilepsy suitable for taking zonisamide as an add-on medication
Locations (10)
Hangzhou Children's Hospital
Hangzhou, Zhejiang, China
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Huzhou Third People's Hospital
Huzhou, Zhejiang, China
Jiaxing Second hospital
Jiaxing, Zhejiang, China
Jinhua Second hospital
Jinhua, Zhejiang, China
The Fourth Affilicated Hospital of Zhejiang University School of Medicine
Jinhua, Zhejiang, China
Lishui People's Hospital
Lishui, Zhejiang, China
Ningbo Women And Children's Hospital
Ningbo, Zhejiang, China
Ningbo Medical center Lihuili hospital
Ningbo, Zhejiang, China
Yuyao People's hospital
Yuyao, Zhejiang, China